Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Sanofi-aventis to Enter Top-10 Club by Doubling Sales: Mr Fauchet
March 24, 2008
- Torrent Withdraws from Japan
March 24, 2008
- REGULATORY NEWS IN BRIEF
March 24, 2008
- Suzuken Renovates Customer Support Services Anticipating Increases in Demand for Generics
March 24, 2008
- Single-Tablet Combination of Galvus and Metformin Approved in EU: Novartis
March 24, 2008
- Nichi-Iko to Become Japan's No. 1 Generic Maker by Acquiring Teikoku Medix
March 24, 2008
- R&D NEWS IN BRIEF
March 24, 2008
- TOPICS 2 articles
March 24, 2008
- BUSINESS NEWS IN BRIEF
March 24, 2008
- Over 50% of Companies to Hire More New Graduates
March 24, 2008
- Japanese Companies Start Voluntary Recall of Heparin Products
March 24, 2008
- Opinion Statement on Closing Vaccine Gap Issued by EFPIA Japan
March 24, 2008
- Korosho Completes Hearings of 16 Leading Manufacturers
March 24, 2008
- Korosho Hears Major Pharmacy Chain Operators
March 17, 2008
- Quintiles Embarks on HMS Business
March 17, 2008
- Claritin Ranked No. 1 in January in Rep Track Survey
March 17, 2008
- NHI Prices Down 10% for ARBs and SSRIs
March 17, 2008
- Most Doctors Don't Like Cravit to Be Replaced with Generics
March 17, 2008
- GENERICS NEWS IN BRIEF
March 17, 2008
- Chugai Actively Participates in Collaborative Multinational Studies
March 17, 2008
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…